First Light Asset Management’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,681,110
| Closed | -$22.1M | – | 42 |
|
2024
Q4 | $22.1M | Sell |
1,681,110
-894,436
| -35% | -$11.8M | 2.12% | 17 |
|
2024
Q3 | $28.9M | Sell |
2,575,546
-825,667
| -24% | -$9.26M | 2.4% | 21 |
|
2024
Q2 | $36.6M | Sell |
3,401,213
-133,780
| -4% | -$1.44M | 3.21% | 14 |
|
2024
Q1 | $52.7M | Sell |
3,534,993
-56,783
| -2% | -$846K | 4.03% | 5 |
|
2023
Q4 | $65M | Buy |
3,591,776
+658,516
| +22% | +$11.9M | 5.23% | 5 |
|
2023
Q3 | $50.9M | Buy |
2,933,260
+1,123,084
| +62% | +$19.5M | 4.83% | 5 |
|
2023
Q2 | $32.8M | Buy |
1,810,176
+384,822
| +27% | +$6.97M | 2.57% | 12 |
|
2023
Q1 | $37.9M | Buy |
1,425,354
+367,473
| +35% | +$9.77M | 3.41% | 10 |
|
2022
Q4 | $20.4M | Buy |
1,057,881
+92,767
| +10% | +$1.79M | 1.9% | 21 |
|
2022
Q3 | $20.2M | Buy |
965,114
+195,744
| +25% | +$4.09M | 2.04% | 21 |
|
2022
Q2 | $6.16M | Buy |
769,370
+358,042
| +87% | +$2.87M | 0.72% | 36 |
|
2022
Q1 | $2.88M | Buy |
411,328
+24,432
| +6% | +$171K | 0.25% | 46 |
|
2021
Q4 | $5.22M | Buy |
+386,896
| New | +$5.22M | 0.37% | 47 |
|